donepezil has been researched along with Urinary Bladder, Overactive in 3 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The study included older adults (aged 65 and older) with a diagnosis of dementia using donepezil, galantamine, or rivastigmine." | 4.12 | Risk of overactive bladder associated with cholinesterase inhibitors in dementia. ( Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML; Masurkar, PP; Sherer, JT, 2022) |
| "Left middle cerebral artery occlusion (MCAO) was performed in female Sprague-Dawley rats." | 1.33 | Acetylcholinesterase inhibitor acting on the brain improves detrusor overactivity caused by cerebral infarction in rats. ( Akino, H; Aoki, Y; Ito, H; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Oyama, N; Shiyama, R; Tanase, K; Yokoyama, O, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Masurkar, PP | 1 |
| Chatterjee, S | 1 |
| Sherer, JT | 1 |
| Chen, H | 1 |
| Johnson, ML | 1 |
| Aparasu, RR | 1 |
| Sakakibara, R | 1 |
| Ogata, T | 1 |
| Uchiyama, T | 1 |
| Kishi, M | 1 |
| Ogawa, E | 1 |
| Isaka, S | 1 |
| Yuasa, J | 1 |
| Yamamoto, T | 1 |
| Ito, T | 1 |
| Yamanishi, T | 1 |
| Awa, Y | 1 |
| Yamaguchi, C | 1 |
| Takahashi, O | 1 |
| Nakai, M | 1 |
| Akino, H | 1 |
| Kaneda, T | 1 |
| Matsuta, Y | 1 |
| Shiyama, R | 1 |
| Tanase, K | 1 |
| Ito, H | 1 |
| Aoki, Y | 1 |
| Oyama, N | 1 |
| Miwa, Y | 1 |
| Yokoyama, O | 1 |
3 other studies available for donepezil and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Humans; Male; Medicare; M | 2022 |
How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
Topics: Aged; Aged, 80 and over; Benzilates; Chi-Square Distribution; Cholinergic Antagonists; Cholinesteras | 2009 |
Acetylcholinesterase inhibitor acting on the brain improves detrusor overactivity caused by cerebral infarction in rats.
Topics: Analysis of Variance; Animals; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Donepe | 2006 |